Trulicity in Steinbach: Once-Weekly Dulaglutide for Type 2 Diabetes From Manitoba Physicians
Trulicity (dulaglutide) is a once-weekly injectable GLP-1 receptor agonist that Health Canada has approved to help adults with type 2 diabetes improve blood-sugar control, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes. TelePlus Care connects Steinbach patients with a licensed doctor through a secure virtual visit. After a clinical assessment and a review of your recent bloodwork, your doctor can — when appropriate — issue a prescription you fill at any Steinbach pharmacy, from a Shoppers Drug Mart on Main Street to a Sobeys or Co-op pharmacy near the Clearspring area. We serve patients across Steinbach and the surrounding southeastern Manitoba communities.
Book Your Appointment Now
Trulicity (dulaglutide) is a once-weekly GLP-1 receptor agonist approved by Health Canada for type 2 diabetes blood-sugar control and to lower cardiovascular risk in adults with type 2 diabetes. It is prescription-only and not approved for weight loss in Canada. TelePlus Care offers Steinbach patients virtual visits with a licensed doctor; A licensed doctor reviews your intake before the visit and explains the safest next step.
- Trulicity is the brand name for dulaglutide, a once-weekly injectable GLP-1 receptor agonist.
- Health Canada has approved Trulicity for the management of type 2 diabetes (glycemic control) in adults.
- It is also indicated to reduce the risk of major cardiovascular events in adults with type 2 diabetes.
- Trulicity requires a prescription after a clinical assessment; it is not a controlled substance and is not approved for weight loss in Canada.
Clinical content is reviewed for accuracy and scope. TelePlus Care appointments proceed only when clinically appropriate after a real assessment, and the doctor will explain the next step if virtual care is not the right fit.
What Is Trulicity and How Does Dulaglutide Work?
Trulicity contains dulaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist delivered once weekly by a single-use pre-filled pen. By mimicking the body's own GLP-1 hormone, it prompts the pancreas to release insulin when blood glucose is high, reduces the amount of glucose the liver makes, and slows the rate at which the stomach empties. Because its action is glucose-dependent, it carries a low risk of causing low blood sugar on its own. For Steinbach adults living with type 2 diabetes, it offers a convenient weekly injection that most patients self-administer at home rather than a daily tablet or injection. Modest weight reduction can occur as a secondary effect, but Trulicity is not approved or marketed in Canada as a weight-loss treatment.
Who May Be a Candidate for Trulicity in Steinbach?
Trulicity is intended for adults with type 2 diabetes. A licensed doctor will review your history, current medications, and recent bloodwork to decide whether it is appropriate for you.
- Adults with confirmed type 2 diabetes who need additional blood-sugar control.
- People who prefer a once-weekly injection over daily diabetes medication.
- Adults with type 2 diabetes and established cardiovascular disease or high cardiovascular risk.
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
- No history of pancreatitis.
- Not currently pregnant or breastfeeding.
- Trulicity is not approved for type 1 diabetes, diabetic ketoacidosis, or as a weight-loss treatment in Canada.
The Virtual Consultation Process at TelePlus Care
Steinbach patients complete the assessment virtually with a licensed doctor. Each prescription is documented and shared with your family doctor on request. We do not dispense medication — we issue prescriptions you fill at any Steinbach pharmacy.
- Step 1: Book online — many Steinbach patients secure a same-day or next-business-day appointment.
- Step 2: Complete an intake form covering your diabetes history, current medications, and recent lab results.
- Step 3: Secure video consultation (15-25 minutes) with your licensed doctor.
- Step 4: Bloodwork review or a new requisition through Shared Health Diagnostic Services if your labs are out of date.
- Step 5: If appropriate, a prescription is issued for any Steinbach pharmacy. Your doctor will explain the once-weekly injection and how to use the pen.
- Step 6: Structured follow-ups to review blood-sugar control, tolerability, and progress.
Bloodwork and Monitoring Before Starting Trulicity
Recent metabolic and organ-function labs help your doctor confirm the diagnosis, set a baseline, and prescribe safely. Shared Health Diagnostic Services provides laboratory collection in Steinbach and across southeastern Manitoba, and your doctor can send a requisition to a convenient location near you.
- HbA1c — confirms diabetes control and provides a baseline for monitoring.
- Fasting plasma glucose.
- Kidney function — eGFR and serum creatinine.
- Liver enzymes — ALT and AST.
- Lipid profile — total cholesterol, LDL, HDL, triglycerides.
- TSH when clinically indicated.
- Pregnancy test for women of reproductive age where appropriate.
Side Effects of Trulicity
Trulicity shares the GLP-1 side-effect profile, with most effects appearing early and easing within the first weeks as your body adjusts. Most are gastrointestinal and mild to moderate.
- Nausea — most common, especially when starting or increasing the dose.
- Diarrhea or constipation.
- Vomiting or indigestion.
- Decreased appetite.
- Injection site reactions — minor redness or itching.
- Hypoglycemia risk increases if combined with insulin or sulfonylureas.
- Rare: pancreatitis — severe abdominal pain radiating to the back; seek urgent care at Bethesda Regional Health Centre or the nearest hospital emergency department.
- Rare: gallbladder problems including gallstones.
Trulicity Compared to Other GLP-1 Therapies
Several GLP-1 receptor agonists are used for type 2 diabetes in Canada. Your doctor will help you weigh convenience, tolerability, cardiovascular benefit, and access.
- Trulicity (dulaglutide) — once-weekly injection with a ready-to-use pen; indicated for blood-sugar control and cardiovascular risk reduction in type 2 diabetes.
- Ozempic (semaglutide) — once-weekly injection, also used for type 2 diabetes.
- Rybelsus (semaglutide) — a daily oral GLP-1 tablet option for type 2 diabetes.
- Victoza (liraglutide) — a daily GLP-1 injection.
- Choice depends on your diabetes profile, other conditions, tolerability, and your doctor's clinical judgment.
Why Steinbach Patients Choose TelePlus Care for Trulicity
TelePlus Care gives Steinbach-area adults with type 2 diabetes timely, evidence-based access to guideline-recommended therapy. Our doctors include a licensed doctor who follows Diabetes Canada guidance. We do not dispense medication — we issue prescriptions you fill at any Steinbach pharmacy, whether that's a Shoppers Drug Mart on Main Street, a Sobeys pharmacy, a Co-op pharmacy near Clearspring, or another local pharmacy in southeastern Manitoba. Same-day virtual visits, clear appointment steps and structured follow-ups are standard. Your intake helps the clinician understand your symptoms, history, and goals before the visit.
Your Fast and Convenient Healthcare Solution
Connect with a licensed healthcare provider from the comfort of your home. No referral needed — book your virtual appointment today.
Book Your Appointment Now
Other Manitoba Locations
We also provide this service in these Manitoba communities:
Teleplus care clinic is not an urgent care clinic. If you have an emergency please call911 or go to the nearest urgent care facility.
